Argenica (ASX:AGN) mark the manufacturing milestone for clinical trials
A manufacturing milestone paves the way to begin Phase 2 clinical trials and towards pivotal Phase 3 and potential partnerships.
A manufacturing milestone paves the way to begin Phase 2 clinical trials and towards pivotal Phase 3 and potential partnerships.
Through a simple reverse flotation step, Cyclone produce a topflight concentrate expected to sell at a premium.
Elixir will direct a bulk of new capital to Daydream expansion while investigating new opportunity in an emerging Super Basin.
Strong cash, no debt, a rosy outlook on energy prices, and excellent adjacent results spur Brookside toward a transformational campaign.
Throughout a challenging 2023 for financial markets, many ASX companies achieved notable success.
Eight of the ten holes have now intersected visible spodumene and come among several pegmatite occurrences at Gorge Lithium.
An unexpected but fortunate pollucite discovery comes to a company with two members involved in one of the few operating mines.
Another high-grade batch includes the deepest deposit assay to date from Never Never as Spartan round out a breakout year at its flagship project.